Cidara Therapeutics Inc (NASDAQ:CDTX) shares are trading lower by 24.4% to $0.52 Monday afternoon. The company announced a 1-for-20 reverse stock split. This decision follows approval from ...

Cidara Therapeutics (CDTX) closed the last trading session at $23.10, gaining 3.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC ...

In a report released today, Joseph Stringer from Needham maintained a Buy rating on Cidara Therapeutics (CDTX – Research Report), with a price target of $35.00. The company’s shares closed ...

In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Cidara Therapeutics (CDTX – Research Report), with a price target of $34.00. The company’s shares ...

NASDAQ CDTX opened at $20.00 on Wednesday. The firm’s fifty day moving average is $21.38 and its two-hundred day moving average is $19.14. The firm has a market cap of $219.06 million, a PE ...

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been given an average rating of “Buy” by the eight analysts that are presently covering the firm, Marketbeat reports.

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC ...

Cidara Therapeutics Inc stock price live, this page displays NASDAQ CDTX stock exchange data. View the CDTX premarket stock price ahead of the market session or assess the after hours quote.